newsfilter
← Latest News
GlobeNewswire·

Nanobiotix to Participate in Investor Conferences in November

  • Nanobiotix announced its management will participate in two investor conferences in November 2026.
  • The Jefferies Global Healthcare Conference is scheduled for Monday, November 16, 2026, in London at 8:30am ET / 1:30pm GMT.
  • CEO Laurent Levy & CFO Arnd Christ will present at the Jefferies event.
  • The UBS Global Biopharma Conference is scheduled for Tuesday, November 17, 2026, in London.
  • Nanobiotix is a late-clinical stage biotechnology company based in Paris, France, with a subsidiary in Cambridge, Massachusetts.
  • The company holds over 30 umbrella patents covering three nanotechnology platforms for oncology, bioavailability, & central nervous system disorders.
  • Nanobiotix is listed on Euronext Paris & the Nasdaq Global Select Market.
Company
Nanobiotix S.A.
Keywords
Paris Stock Exchange:NANO, Nanobiotix S.A.